Etoposide phosphate [clinicaltrials_resource:c16b1010e56ec897fd8124c88360bb44]
Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy [clinicaltrials:NCT00000807]A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection [clinicaltrials:NCT00001339]Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas [clinicaltrials:NCT00002003]clinicaltrials:NCT00002558Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002649]Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas [clinicaltrials:NCT00002876]clinicaltrials:NCT00002880Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia [clinicaltrials:NCT00002912]clinicaltrials:NCT00002941clinicaltrials:NCT00002943Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00002961]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003064]clinicaltrials:NCT00003084Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00003190]clinicaltrials:NCT00003299Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00003380]clinicaltrials:NCT00003573Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003575]Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003597]clinicaltrials:NCT00003621clinicaltrials:NCT00003625Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00003875]Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003967]clinicaltrials:NCT00003996clinicaltrials:NCT00004054Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma [clinicaltrials:NCT00004110]clinicaltrials:NCT00005792A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide [clinicaltrials:NCT00005793]clinicaltrials:NCT00006012Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia [clinicaltrials:NCT00006040]Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide [clinicaltrials:NCT00006047]clinicaltrials:NCT00006373clinicaltrials:NCT00006487Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer [clinicaltrials:NCT00011921]Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer [clinicaltrials:NCT00017251]clinicaltrials:NCT00017368Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00020709]clinicaltrials:NCT00020722Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00027898]clinicaltrials:NCT00028769
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Etoposide phosphate [clinicaltrials_resource:c16b1010e56ec897fd8124c88360bb44]
Bio2RDF identifier
c16b1010e56ec897fd8124c88360bb44
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c16b1010e56ec897fd8124c88360bb44
identifier
clinicaltrials_resource:c16b1010e56ec897fd8124c88360bb44
title
Etoposide phosphate
@en
type
label
Etoposide phosphate [clinicaltrials_resource:c16b1010e56ec897fd8124c88360bb44]
@en